REMUS Remus Pharmaceuticals Ltd Company Mergers Announcement 2026 - Disclosure under Regulation 31(4) Promoters report no encumbrance on shares for FY2026; Regulation 31(4) disclosure filed with NSE..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Remus Pharmaceuticals Ltd